Hydroxychloroquine dose: balancing toxicity and SLE flare risk

被引:13
|
作者
Lenfant, Tiphaine [1 ,2 ]
Costedoat-Chalumeau, Nathalie [1 ,2 ]
机构
[1] Cochin Hosp, AP HP, Dept Internal Med, Ctr Reference Malad Autoimmunes & Syst Rares Fran, Paris, France
[2] Univ Paris Cite CRESS, Ctr Epidemiol & Stat, INSERM, U1153, Paris, France
关键词
RETINOPATHY;
D O I
10.1038/s41584-022-00868-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Contemporary guidelines for the management of systemic lupus erythematosus (SLE) recommend prescribing hydroxychloroquine dosages of 5 mg/kg per day or lower to minimize toxicity. However, new evidence raises serious concerns about the risk of SLE flare associated with such doses. How do the benefits and risks of this controversial recommendation balance out?
引用
收藏
页码:6 / 7
页数:2
相关论文
共 50 条
  • [1] Hydroxychloroquine dose: balancing toxicity and SLE flare risk
    Tiphaine Lenfant
    Nathalie Costedoat-Chalumeau
    Nature Reviews Rheumatology, 2023, 19 : 6 - 7
  • [2] Risk of flare in patients with SLE in remission after hydroxychloroquine or chloroquine withdrawal
    Trefond, Ludovic
    Mathian, Alexis
    Lhote, Raphael
    De Chambrun, Marc Pineton
    Pha, Micheline
    Hie, Miguel
    Miyara, Makoto
    Papo, Matthias
    Moyon, Quentin
    Taieb, Dov
    Abdallah, Nassim Ait
    Chasset, Francois
    Aubart, Fleur Cohen
    Haroche, Julien
    Zahr, Noel
    Amoura, Zahir
    JOINT BONE SPINE, 2024, 91 (06)
  • [3] Hydroxychloroquine Dose Reduction and SLE Flares
    Jorge, April
    Ho, Gary
    Wu, Michael
    Costenbader, Karen
    Choi, Hyon
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [5] HYDROXYCHLOROQUINE TOXICITY DESPITE NORMAL DOSE THERAPY
    FALCONE, PM
    PAOLINI, L
    LOU, PL
    ANNALS OF OPHTHALMOLOGY, 1993, 25 (10): : 385 - 388
  • [6] Reductions in Anti-dsDNA antibodies and reduced risk of SLE renal flare and major SLE flare.
    Linnik, MD
    Joh, T
    Tumlin, JA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 450A - 450A
  • [7] Hydroxychloroquine has a positive effect on the Mortality Risk in Patients with SLE
    不详
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2019, 78 (10): : 911 - 911
  • [8] Risk of Retinal Toxicity in Longterm Users of Hydroxychloroquine
    Kim, Ji-Won
    Kim, Yoon Young
    Lee, Hwajeong
    Park, Sung-Hoon
    Kim, Seong-Kyu
    Choe, Jung-Yoon
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (11) : 1674 - 1679
  • [9] SLE PREGNANCIES AT HIGH RISK FOR PRE-ECLAMPSIA BENEFIT MOST FROM COMBINATION OF LOW DOSE ASPIRIN AND HYDROXYCHLOROQUINE
    Haase, I.
    Chehab, G.
    Sander, O.
    Schneider, M.
    Fischer-Betz, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1195 - 1196
  • [10] SLE Subgroups at Risk for Poor Outcomes After Hydroxychloroquine Taper or Discontinuation
    Almeida-Brasil, Celline
    Vinet, Evelyne
    Pineau, Christian
    Kalache, Fares
    Grenier, Louis-Pierre
    Bernatsky, Sasha
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1079 - 1079